Product Information
Registration Status: ActiveSIN03214P
MESTINON TABLET 10mg is approved to be sold in Singapore with effective from 1989-12-06. It is marketed by A. MENARINI SINGAPORE PTE LTD, with the registration number of SIN03214P.
This product contains Pyridostigmine 10mg in the form of TABLET, SUGAR-COATED. It is approved for ORAL use.
This product is manufactured by LABIANA PHARMACEUTICALS SL in SPAIN.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Description
A cholinesterase inhibitor with a slightly longer duration of action than neostigmine. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants. [PubChem]
Indication
For the treatment of myasthenia gravis.
Mechanism of Action
Pyridostigmine inhibits acetylcholinesterase in the synaptic cleft by competing with acetylcholine for attachment to acetylcholinesterase, thus slowing down the hydrolysis of acetylcholine, and thereby increases efficiency of cholinergic transmission in the neuromuscular junction and prolonges the effects of acetylcholine.
Pharmacokinetics
- Absorption
- Poorly absorbed from the GI tract with an oral bioavailability of 7.6 +/- 2.4%.
- Distribution
- Metabolism
- Hydrolysis by cholinesterases and by liver.
- Elimination
Active Ingredient/Synonyms
Bromure de Pyridostigmine | Bromuro de piridostigmina | Pyridostigmin bromid | Pyridostigmine | Pyridostigmini Bromidum | Pyridostigmine |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.